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ABSTRACT 
Alcoholic fatty liver disease is often complicated by other pathological insults, such as viral 
infection or high fat diet.  Autophagy plays a homeostatic role in the liver but can be 
compromised by alcohol, high fat diet, or viral infection, which in turn affect the disease process 
caused by these etiologies.  To understand the full impact of autophagy modulation on alcohol-
induced liver injury, several genetic models of autophagy deficiency, which have different levels 
of functional alterations, were examined following acute binge or chronic-plus-binge treatment.  
Alcohol given in either mode to the liver-specific inducible Atg7-deficient mice shortly after the 
induction of Atg7 deletion had an elevated liver injury, indicating the protective role of 
autophagy. Constitutive hepatic Atg7 deficient mice, in which Atg7 was deleted in embryos, 
were more susceptible to chronic-plus-binge but not to acute alcohol treatment. Constitutive 
hepatic Atg5 deficient mice, in which Atg5 was deleted in embryos, were more prone to acute 
alcohol treatment, but liver injury were surprisingly improved in the chronic-plus-binge regime. 
A prolonged autophagy deficiency may complicate the hepatic response to alcohol treatment, 
likely in part due to endogenous liver injury. The complexity of the relationship between 
autophagy deficiency and alcohol-induced liver injury can thus be affected by the timing of 
autophagy dysfunction, the exact autophagy gene being affected, and the alcohol treatment 
regime.  
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INTRODUCTION 
The liver plays a critical role in metabolism in the body 1. When metabolic homeostasis is 
disturbed in the liver, fatty liver disease (FLD) can occur, which is characterized by steatosis, 
inflammation, and fibrosis. FLD can be classified as the one caused by excessive alcohol intake 
(alcoholic fatty liver disease, AFLD) and the other that is caused by any non-alcohol etiologies 
(nonalcoholic fatty liver disease, NAFLD) 2. 
Autophagy is an evolutionarily conserved cellular degradation process, which involves the 
delivery of cytoplasmic cargo (macromolecules or organelles) to the lysosome 3. Three types of 
autophagy have been defined, ie, macroautophagy, microautophagy, and chaperone-mediated 
autophagy 4. Macroautophagy is quantitatively the most active form of autophagy and referred 
to hereafter as autophagy. In macroautophagy, cytosolic materials are sequestered inside the 
autophagosome, and transported to and degraded in the lysosome 5. Autophagy occurs at the 
basal level in the liver and can be further enhanced under stressed conditions. It can play an 
important role in the maintenance of normal liver functions and in the pathogenesis of different 
liver diseases 6, 7. In particular, autophagy could be activated or depressed in such common liver 
diseases as AFLD 8, 9, 10, 11, 12, NAFLD 13, 14, 15 and hepatitis virus infection 16-19.  
The pathological processes of AFLD are considered to be related to oxidative stress caused by 
accumulation of acetaldehyde, increase of the NADH/NAD+ ratio, or generation of reactive 
oxidative species (ROS) 20-22. Oxidative stress may induce functional and structural changes of 
mitochondria during the progress of AFLD, which affect oxidative phosphorylation, increase 
mitochondrial DNA damage, and alter mitochondrial protein profiles 23-28. Increased reactive 
oxygen species, together with alcoholic steatosis, lead to lipid peroxidation that can further 
enhance oxidative damage in AFLD 29. As shown in previous studies, effects of autophagy can 
vary at different pathological stages of AFLD. Autophagy is activated in the liver in vivo and in 
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cultured primary hepatocytes after acute alcohol treatment 8, 9 30. This activation requires alcohol 
metabolism, and is mediated by reactive oxygen species, and several signaling pathways. 
Acetaldehyde, a major alcohol metabolite and a pro-oxidant, has been implicated in the 
induction of autophagy 31. Meanwhile, alcohol-induced autophagy can be suppressed by anti-
oxidants, such as N-acetyl cysteine (NAC) 8, 32. In addition, alcohol treatment also alters the 
mammalian target of rapamycin (mTOR), 5' AMP-activated protein kinase (AMPK), and/or 
Forkhead box O3 (FOXO3a) signaling pathways 33-35, which can contribute to the change of 
autophagy process. Other autophagy stimulators, including alcohol-induced endoplasmic 
reticulum (ER) stress, proteasome inhibition, and metal elements such as zinc, are also 
implicated in the autophagy dynamics following alcohol treatment 36-38.  
Interestingly, autophagy may be suppressed in chronic alcohol treatment or in other liver 
diseases. When mice were fed with Lieber-DeCarli diet for four weeks, hepatic autophagy was 
stimulated at a lower dose of alcohol (accounting for 29% of the caloric need) but was inhibited 
at a higher alcohol dose (accounting for 36% of the caloric need) 15. The suppression of 
autophagy by long-term alcohol use may suggest that promotion of autophagy can improve the 
condition. The cause of the autophagy suppression may include the decrease in both the 
amount and the function of lysosomes, which was found in chronic alcohol-treated rat livers 10, 11, 
39
. Indeed, a recent study suggested that the level of transcription factor EB (TFEB), which plays 
a critical role in lysosomal biogenesis and autophagy, was decreased in the livers of mice given 
alcohol diet and of patients with alcohol-induced hepatitis 12. Disruption of hepatic TFEB 
enhanced alcohol-induced liver injury in mice, but increase of TFEB level led to reduced 
alcohol-induced liver injury through elevated lysosomal biogenesis and mitochondrial 
bioenergetics 12.  
Nevertheless, the assessment of the contribution of autophagy to alcohol-induced liver injury 
had been mainly conducted through acute pharmacological manipulation or acute knockdown of 
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certain autophagy-related genes. The role of autophagy, particularly in the prolonged deficient 
status, has not been assessed for the impact on alcoholic liver diseases.  This may be important 
as alcohol liver disease is often complicated by other disease-causing factors, such as viral 
infection or high fat diet, which can compromise autophagy. The present study thus employed 
several genetic models of autophagy deficiency and assessed the effects of alcohol under 
different autophagy functional status. The findings suggest that the complicated interaction of 
alcohol and autophagy in liver injury can be affected by the timing of autophagy dysfunction, the 
exact autophagy gene being affected, and the alcohol treatment regime.  
 
MATERIALS AND METHODS 
Mice 
 Atg5F/F mice (B6.129S-Atg5tm1Myok) 40 and Atg7F/F mice 41  have been reported in previous 
studies. Atg5∆hep Atg7∆hep mice were generated by crossing Atg5F/F or Atg7F/F with the Alb:Cre 
transgenic mice (The Jackson Laboratory, Bar Harbor, ME), respectively. The liver-specific 
inducible Atg7-deficient mice (Atg7∆hep-ERT2) were generated by crossing Atg7F/F mice to Alb:Cre-
ERT2 mice 42. Deletion of Atg7 was induced by administration of tamoxifen (6 mg/day, x2 days, 
s.c.). Mice were maintained on a 12-hour dark/12-hour light cycle with free access to food and 
water. Both male and female mice were used in the studies. Age- and sex-matched mice were 
randomly assigned to treatment or control group. 
Animal models 
Acute alcohol binge was conducted as previously described 8. After six hours of fasting, mice 
were given 31.5% (vol/vol) alcohol by gavage at a total accumulative dosage of 5 g/kg 
bodyweight in four equally divided doses in 20 min intervals. For Atg7∆hep-ERT2 and the control 
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Atg7F/F mice, they were injected with tamoxifen (6 mg/mouse, s.c. daily x2) 7 days before they 
were given acute alcohol binge as above or as indicated in the figure legends. The control mice 
were given the same volume of water. 
The chronic-plus-binge model was conducted as previously described 43. Mice were acclimated 
with liquid control food for 5 days. The alcohol groups were then given a liquid diet containing 
5% (w/v) alcohol for 10 days. Pair-fed groups were given the same volume of control food. In 
the early morning of day 11, mice in the alcohol groups were given a single dose of 31.5% 
(vol/vol) alcohol (5 g/kg bodyweight) by gavage. Pair-fed mice were given an isocaloric dose of 
dextrin maltose by gavage. After nine hours, the mice were euthanized, and blood and tissue 
samples were collected.  
All animal experiments were approved by the Institutional Animal Care and Use Committee 
(IACUC) of Indiana University. 
Antibodies and chemicals 
Antibodies and PCR primers used in this study are listed in Table 1 and Table 2, respectively. 
Tamoxifen (Sigma-Aldrich, St. Louis, MO) were diluted in corn oil. Alcohol (190 proof, Decon 
Labs, King of Prussia, PA) was diluted in water or added to a formulated liquid diet 43. Lieber-
DeCarli ‘82 Shake and Pour alcohol liquid diet (Bio-Serv, product no. F1258SP) was used as 
the alcohol diet. Lieber-DeCarli ‘82 Shake and Pour control liquid diet (Bio-Serv, product no. 
F1259SP) was used as the control diet. 
Serum biochemistry analysis 
Serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline 
phosphatase (ALP), triglycerides (TG), and total cholesterol (TCHO) were measured using kits 
from Pointe Scientific (Canton, MI) according to the manufacturer’s protocol. Serum total bile 
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acids (TBA) were measured using total bile acids assay kit from Diazyme Laboratories, Inc 
(Poway, CA).  
Hepatic lipid content analysis 
A piece of liver tissue was weighed and incubated in 1 mL of chloroform-methanol mix (2:1, v/v) 
with shaking for one hour at room temperature to extract lipids. After addition of 200 µL of water, 
samples were vortexed and centrifuged at 3,000 × g for 5 minutes. The lower lipid phase was 
collected and dried at room temperature in a chemical hood. The lipid pellet was re-suspended 
in 60 µL of tert-butanol and 40 µL of a Triton X-114-methanol (2:1, v/v) mix. Triglycerides and 
cholesterol contents were measured, using respective kits from Pointe Scientific (Canton, MI). 
The lipid contents hence were normalized with the tissue weight. 
Hepatic TBA content analysis 
Liver tissue (100 mg) samples were homogenized in 1 mL of 90% alcohol and incubated at 55 
°C overnight. The lysates were centrifuged at 10,00 0 rpm for 10 min. The supernatants were 
collected and measured for total bile acid concentration using total bile acids assay kit from 
Diazyme Laboratories, Inc (Poway, CA). 
Immunoblotting analysis 
The liver samples were homogenized in the radio immunoprecipitation assay buffer (RIPA) 
containing a protease cocktail. Supernatant was collected after centrifuged at 12,000×rpm for 
12 min. Protein concentration was determined using BCA protein assay kit (Thermo Fisher 
Scientific-Pierce). The proteins were separated on a sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE). Proteins were transferred onto polyvinylidene fluoride (PVDF) 
membranes, which were then blocked with 5% BSA or 5% skim milk for one hour at room 
temperature. Membranes were incubated with the appropriate primary antibody overnight and 
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then washed with TBST (Tris-buffered saline, 0.1% Tween 20) before being incubated with the 
horseradish peroxidase–coupled secondary antibodies at room temperature. Protein bands 
were detected using enhanced chemiluminescence (ECL) kit (Thermo Fisher Scientific-Pierce). 
The images were taken digitally with a BioRad ChemiDoc Image System (BioRad, Hercules, 
CA). Densitometry was measured using the companion software, and the values were 
normalized to that of β-actin or GAPDH, which were then converted to fold change of the 
control.  
RNA isolation and quantitative real-time PCR analysis 
Total RNA was prepared from liver samples using GeneTET RNA purification kit (Thermo Fisher 
Scientific, Grand Island, NY) according to the manufacturer’s protocols. Complementary DNA 
(cDNA) was synthesized using Oligo dT primers and an M-MLV reverse transcriptase system 
(Life Technologies-Thermo Fisher Scientific). Quantitative real-time PCR analysis (RT-qPCR) 
was performed on a 7500 Real-Time PCR System (Life Technologies-Applied Biosystems) 
using SYBR Green master mixes (Life Technologies-Applied Biosystems). All RT-qPCR results 
were normalized to the level of β-actin and the gene expression was calculated using the 2-∆∆Ct 
method. 
Histological study 
Liver samples were harvested, rinsed with PBS, and fixed in 10% formalin overnight. Samples 
were further fixed in 70% alcohol and processed as paraffin-embedded blocks. The paraffin-
embedded tissues were sectioned and stained with hematoxylin and eosin (H&E), anti-F4/80, or 
Mason’s Trichrome C. Photomicrographs were taken using a Nikon Eclipse E200 light 
microscope equipped with a SPOT RT Slider color digital camera (Diagnostic Instruments, Inc, 
Sterling Heights, MI). Area with positive F4/80 or Mason’s Trichrome C staining were quantified 
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using ImageJ software (NIH), at least four random fields of each section from each mouse liver 
were used for quantification. 
Immunofluorescence microscopy 
Paraffin sections were subjected to antigen retrieval treatment using the Citrate buffer (0.01M, 
pH 6.0) after deparaffinization. Slides were blocked with 5% goat serum in PBS containing 0.1% 
Triton X (PBS-Tx) for one hour and then incubated with primary antibodies diluted in 1% bovine 
serum albumin (BSA)/PBS-Tx overnight at 4 °C. Secti ons were washed with PBS, following by 
incubation with fluorochrome-conjugated secondary antibodies. Hoechst 33342 was used for 
nucleus staining. Images were obtained using a Nikon Eclipse TE 200 epi-immunofluorescence 
microscope and the companion NIS-Elements AR3.2 software. Quantification was performed 
using ImageJ software (NIH), at least four random fields of each section from each mouse liver 
were analyzed. 
Alcohol clearance analysis 
Mice were given a single dose of 31.5% (vol/vol) alcohol by gavage (5 g/kg bodyweight). Blood 
were sampled from the tail vein before the treatment and at 1, 3, and 9 hours after gavage. 
Alcohol concentration was measured in the plasma using an alcohol colorimetric/fluorometric 
assay kit (BioVision Inc., Milpitas, CA). 
Statistical analysis 
Statistical analyses were performed using SPSS for Windows 17.0 Software (SPSS, Inc., 
Chicago, IL) or Microsoft Excel 2016. Student’s t-test was used to determine differences 
between two groups. Differences between more than two treatment groups were determined 
using one-way analysis of variance (ANOVA) followed by Duncan’s post-hoc test. Data were 
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represented as means with standard errors (mean ± S.E.). Results were considered statistically 
significant for P-value < 0.05. 
RESULTS 
Genetic deletion of a key autophagy gene enhances liver injury induced by acute alcohol 
binge 
To evaluate the effects of hepatic autophagy deficiency on ALDs, one single binge dose of 
alcohol was administered to the Atg5∆hep mice and the control mice (Fig.1A). Hepatic Atg5 
deficiency induced significant hepatomegaly and liver injury (Fig. 1B). Serum levels of ALT, 
AST, and ALP, and total hepatic TG, but not hepatic cholesterol levels, were further elevated in 
Atg5∆hep mice following alcohol treatment (Fig.1B), suggesting that acute alcohol treatment 
exacerbated the liver pathology in these mice. A protective function of autophagy against 
hepatic steatosis induced by acute alcohol administration has been shown in several studies 8, 15, 
30, 31
.  
Genetic deletion of Atg7 in hepatic parenchymal cells caused a more severe liver phenotype 
than that seen in Atg5∆hep mice40 (Fig. 1C). In these mice a single binge dose of alcohol did not 
further lead to notable increases in serum levels of liver markers and hepatic TG level (Fig.1C). 
It seemed that a constitute deletion of Atg7 in hepatic parenchymal cells causes too severe an 
injury that the relative minor effects of acute alcohol treatment were blunted.  
To separate the injury effect caused by constitutive Atg7 deletion and alcohol treatment, 
Atg7∆hep-ERT2 mice were injected with tamoxifen to induce an acute deletion of Atg7 in the liver 
before alcohol treatment (Fig. 1D). The deficiency of hepatic autophagy in Atg7∆hep-ERT2 mice 
following tamoxifen injection was confirmed by immunoblotting demonstration of decreases in 
hepatic LC3II/ LC3I ratio and accumulation of SQSTM1/p62 protein (Supplemental Fig S1). 
Obvious hepatomegaly and serum elevation of liver injury markers in the Atg7∆hep-ERT2 mice was 
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not observed in 9 days after induction; however, the serum markers and hepatic TG levels were 
significantly increased following the acute alcohol treatment in these mice (Fig. 1E). The results 
were consistent with previous results in which autophagy was modified transiently and acutely 
using chemicals or gene knockdown 8, 9, 15. Therefore, an acute deletion of Atg7, while not 
causing liver injury alone, rendered the hepatocytes more susceptible to alcohol.  
Acute deletion of Atg7 gene enhances alcohol-induced liver injury in a chronic-plus-
binge model 
To further examine the impact of hepatic autophagy deficiency alcohol exposure, the response 
of these genetically altered mice was analyzed to a more chronic alcohol exposure using a 
recently established chronic-plus-binge model 43 (Fig. 2A). Atg7∆hep-ERT2 and Atg7F/F mice were 
given tamoxifen at day 3 and 4 in a 5-day acclimation period, followed by an alcohol diet for 10 
days plus an acute alcohol binge at the end of the feeding period. Autophagy deficiency was 
confirmed as indicated by the reduced level of ATG7 and LC3II/LC3I ratio and an elevated 
SQSTM1/p62 in the liver of Atg7∆hep-ERT2 mice (Fig. 2B and C). Consistently, nuclear factor 
erythroid 2–related factor 2 (NRF2) was activated and its targets, glutathione S-transferase M1 
(Gstm1) and NAD(P)H quinone dehydrogenase 1 (Nqo1), was expressed at a much higher level 
in the liver of Atg7∆hep-ERT2 mice (Fig. 2B-2D). Notably, alcohol treatment did not alter these 
changes due to Atg7 deletion, although it increased the LC3II/LC3I ratio in the floxed normal 
mice (Fig. 2B-2D).   
A longer duration of Atg7 deletion in the Atg7∆hep-ERT2 mice resulted in enlarged livers and liver 
injury in the chronic-plus-binge model (Fig.2E) as compared with the shorter duration of deletion 
in the binge model (Fig.1E). But as in the binge model, the hepatomegaly and liver injury 
phenotype (ALT and AST levels), but not that of ALP and TBA, were further augmented by 
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alcohol treatment (Fig.2F).These results suggested a protective function of Atg7-mediated 
autophagy in alcohol-induced liver injury. 
To determine potential factors that promote injury in autophagy deficiency, the extent of 
steatosis was examined.  Hepatic TG (Fig. 2G), but not TCHO (Supplemental Fig. S2A), levels 
were altered after alcohol treatment, indicating the presence of steatosis in the liver of both 
Atg7F/F and Atg7∆hep-ERT2 mice but the difference was not significant between the two types of 
mice. Consistently, alcohol-induced elevation of fatty acid–oxidation as measured by the serum 
level of β-hydroxybutyrate (β-OHB) was not altered in the absence of Atg7 (Fig. 2G).   
Histological examination suggested no obvious differences in general structure and fibrosis, but 
an elevated presence of Kupffer’s cells in autophagy deficient livers (Supplemental Fig. S2B-E).  
Two acute phase proteins, LCN-2 and SAA2, which are secreted by hepatocytes and other 
extrahepatic tissues in response to stress or injury, have been recently found to promote 
alcoholic liver pathology 44, 45.  Indeed, expression of both LCN2 and SAA2 were elevated in 
Atg7∆hep-ERT2 livers, likely in response to autophagy deficiency–induced stress (Supplemental 
Fig. S3A).  Following the 10-day chronic plus binge alcohol treatment the expression of LCN2 
and SAA1 was elevated in floxed-control mice, but not higher than the already elevated level in 
the Atg7-deficient livers (Supplemental Fig. S3A).  In addition, the mRNA levels of several 
inflammatory cytokines and inflammatory cell markers were higher in alcohol-treated Atg7∆hep-
ERT2
 livers than in the same treated floxed mice (Supplemental Fig. S3B-C).  But several of 
them, such as Ccl2 and Tlr4, were also elevated in Atg7∆hep-ERT2 livers without alcohol treatment.  
These findings suggest that the protective effect of autophagy may not be entirely related to 
modulation of inflammation.   
Constitutive deletion of hepatic Atg7 exacerbates alcohol-induced liver injury in a 
chronic-plus-binge model 
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Chronic alcohol treatment caused more injury than acute binge treatment (Fig 2E vs Fig 1E), 
which could allow the detection of Atg7-mediated protection even in the constitutive deletion 
model.  Thus, Atg7∆hep and the control mice alcohol were administered diet using the chronic-
plus-binge scheme (Fig.3A). As in the inducible Atg7∆hep-ERT2 mice, alcohol diet did not 
significantly alter the reduced level of ATG7 and LC3II/ LC3I ratio, and the accumulation of 
SQSTM1 and NQO1 in the liver of Atg7∆hep mice (Fig.3B and C). Alcohol enhanced 
hepatomegaly (Fig. 3D) and liver injury based on the increased serum level of ALT and AST 
(Fig.3E). There were no significant differences in the serum level of ALP and TBA with or 
without alcohol treatment (Fig.3E). In addition, total hepatic TG and TCHO levels were 
increased in Atg7-deficient liver by alcohol treatment (Fig.3F). These results indicated that 
constitutive loss of Atg7 may exacerbate injury caused by chronic alcohol treatment as well.  
Constitutive deletion of hepatic Atg5 does not enhance liver injury in a chronic-plus-
binge model  
A single dose of alcohol binge treatment enhanced liver injury in Atg5∆hep mice (Fig.1B). Chronic 
alcohol treatment of Atg5∆hep mice (Fig. 4A) did not result in significant alterations in the 
repression of autophagy in these mice (Fig.4B-D). Alcohol treatment slightly increased 
hepatomegaly in younger Atg5∆hep mice (Fig.4E), but significantly decreased the serum levels of 
ALT, AST, and ALP in both younger and older Atg5∆hep mice (Fig.4F-H).  The reduced injury was 
observed in both male and female mice (Supplemental Fig. S4A and Supplemental Fig. S5A). 
Total hepatic TG level but not cholesterol level was still increased in Atg5∆hep and in Atg5F/F mice 
following alcohol treatment (Fig.4I-4L, Supplemental Fig. S4B, Supplemental Fig. S5B), 
indicating an expected hepatic response to alcohol. Consistent with a higher level of total 
hepatic TG in Atg5∆hep mice following alcohol treatment, hematoxylin and eosin staining of the 
liver sections also showed a more prominent hepatic steatosis in these mice (Fig.5A).  
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It is well established that elevation of hepatic TG level is an immediate consequence of alcohol 
stimulation and steatosis is also a major pathological phenomenon in AFLD 46, 47 . Generally, 
alcohol can affect hepatic lipid metabolism by accelerating lipogenesis, decelerating lipid 
breakdown, and causing defective hepatic lipids export47.  The mRNA expression of several lipid 
metabolism related–genes in the Atg5∆hep mice was altered from that in the Atg5F/F mice before 
and/or after alcohol treatment (Supplemental Fig.S6A-E).  Genes involved in lipid secretion, 
such as apolipoprotein B (Apob) and apolipoprotein E (Apoe), was reduced, whereas 
expression of genes involved in lipid update was increased before or after alcohol treatment, 
such as cluster of differentiation 36 (Cd36) and lipoprotein lipase (Lpl).  Although expression of 
genes involved in lipogenesis was not elevated, except stearoyl coenzyme A desaturase 1 
(Scd1), expression of genes involved in lipolysis, such as adipose triglyceride lipase (Atgl) and 
hormone sensitive lipase E (Lipe), and genes in lipid oxidation, such as acyl-CoA 
dehydrogenase long chain (Acadl), acyl-CoA dehydrogenase medium chain (Acadm), 
peroxisomal acyl-coenzyme A oxidase 1 (Acox1), and peroxisome proliferator-activated receptor 
alpha (Ppar-α), were repressed.  Moreover, expression of genes involved in lipid oxidation was 
overall reduced in Atg5∆hep mice (Supplemental Fig. S6E); however, the serum level of β-OHB 
remained elevated in response to alcohol stimulation (Supplemental Fig. S6F). These changes 
may overall favor the accumulation of lipids in the cells and decrease lipid use.   
The number of F4/80+ staining macrophages was significantly increased in Atg5∆hep livers, 
similar to what was observed in Atg7∆hep livers48.  The level of macrophage expansion was 
noticeably reduced by alcohol treatment (Fig.5B and C). The expression level of many 
inflammation-related genes was not significantly altered in Atg5-deficient livers, except C-C 
motif chemokine ligand 2 (Ccl2), which was increased in Atg5-deficient livers (Supplemental 
Fig.S7).  Alcohol treatment reduced the levels of Ccl2 and several other cytokines and 
inflammatory cell markers in these mice (Supplemental Fig.S7A-B). On the other hand, the 
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expression level of LCN2 and SAA2 remained higher (Supplemental Fig. S7C). Inflammation 
plays important roles in the pathogenesis of ALFD 49. In particular CCL2 is associated with the 
severity and neutrophil infiltrates in ALD 50. Thus, the reduction of inflammation in chronic 
alcohol treatment condition may contribute to the reduced injury level in Atg5∆hep livers. 
Interestingly, the significantly elevated fibrosis in Atg5-deficient livers was also decreased by 
chronic alcohol treatment as shown by Masson’s trichrome staining (Fig.5D and E), 
hydroxyproline level (Fig. 5F), and the expression of α-smooth muscle actin (α-SMA), at the 
protein (Fig. 5G) and the mRNA levels (Fig. 5H). Other fibrosis related genes such as 
connective tissue growth factor (Ctgf), transforming growth factor beta 1 (Tgf-β), TIMP 
metallopeptidase inhibitor 1 (Timp1), and glial fibrillary acidic protein (Gfap) did not show 
significant differences between alcohol treatment and control diet (Fig.5H).  This improving 
effect of alcohol is reminiscent of an earlier study showing a potentially protective effect of light 
alcohol consumption on hepatocellular injury and liver fibrosis in NAFLD patients 51. It seems 
that alcohol may have variable effects on hepatic fibrosis under different pathological conditions, 
which may partially explain the improvement of liver fibrosis in Atg5-deficient livers following 
alcohol treatment. 
Reduction in cholestatic injury in Atg5-deficient livers following alcohol treatment 
Autophagy deficiency in the liver can cause cholestatic injury, which is accompanied by a 
significant ductular reaction 48, 52. Alcohol treatment reduced this pathological change in Atg5∆hep 
livers as measured by the level of cytokeratin 19 (CK19) positive ductular cell (Fig.6A and B). 
Consistently, the serum level of total bile acids (TBA) was also decreased in Atg5∆hep mice 
following alcohol treatment in both sexes and at both the older (Fig.6C) and younger ages 
(Supplemental Fig. S8A). Similar chronic alcohol treatment of Atg7∆hep-ERT2 (Fig. 2F) or Atg7∆hep 
(Fig. 3E) did not reduce the elevated serum TBA levels in these mice. Unexpectedly, the hepatic 
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TBA load remained high in Atg5∆hep mice even following alcohol treatment regardless of ages 
(Fig.6D and E, Supplemental Fig. S8B and C). Interestingly, Atg5∆hep mice given one dose of 
alcohol binge also showed a reduced serum bile acid level, in contrast to Atg7∆hep and Atg7∆hep-
ERT2
 mice given the same acute treatment (Supplemental Fig. S8D). 
The mRNA levels of genes related to bile acid metabolism were analyzed to determine any 
potential effects of alcohol. The expression of many of these genes was decreased in Atg5-
deficient livers as previously reported 52 (Supplemental Fig.S9). However, overall, the mRNA 
levels of genes related to BAs synthesis were not further significantly altered in Atg5-deficient 
liver following alcohol treatment (Supplemental Fig.S9A-S9B). In addition, the expression of 
genes related to FXR signaling remained low in Atg5-deficient livers (Supplemental Fig.S9C). 
The impact of autophagy deficiency on the expression of the bile acid transporters was as 
reported before 52, most of which were not further significantly affected by the alcohol 
(Supplemental Fig.S9D-S9F).  Exceptions were the expression of organic solute transporter 
beta (Ost-β) in Atg5∆hep liver (Supplemental Fig.S9E) and that of Oatp1 in Atg5F/F liver 
(Supplemental Fig.S9F), which were significantly decreased following alcohol treatment. Gene 
expression results indicated that the influence of alcohol on the bile acid metabolism of Atg5-
deficient livers would likely be limited.  
Hepatic Atg5 deficiency alters the expression of genes related to alcohol metabolism and 
the plasma alcohol clearance rate in mice 
Acetaldehyde along with other alcohol metabolites are considered to be responsible for 
alcoholic liver diseases 53. Since alcohol-induced liver injury is affected by alcohol metabolism, it 
was tested whether alcohol metabolism was affected in Atg5-deficient livers. The expression of 
genes related to alcohol metabolism was analyzed. Notably, the mRNA levels of several alcohol 
dehydrogenase (ADH) genes, including ADH Class I (Adh1), ADH Class III (Adh5), ADH Class 
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IV (Adh7), and ADH Class II (Adh4), were decreased in Atg5-deficient livers (Fig.7A). The 
expression level of cytochrome P450 family 2 subfamily E member 1 (Cyp2e1), and catalase 
(Cat) was also decreased in Atg5-deficient livers (Fig.7A). Interestingly, the mRNA level of 
Adh1, Adh4, Adh5, Cyp2e1, and Cat was also decreased in livers of Atg5F/F mice after alcohol 
treatment.  
The mRNA level of several aldehyde dehydrogenases (ALDHs) in the liver was analyzed. A 
significant decrease in the mRNA expression levels of Aldh2, Aldh4a1, Aldh5a1, Aldh7a1, 
Aldh8a1, and Aldh9a1 was observed in Atg5-deficient livers (Fig.7B). Although alcohol did not 
seem to cause further changes in expression for most of these genes, it elevated Aldh1a3 gene 
expression in Atg5-deficient livers, and Aldh18a1 gene expression in Atg5F/F livers (Fig.7B). 
Expression of several other Aldh family members, including Aldh1a1, 1a2, 1b1, 1l1, 1l2, 3a2, 
3b1, and 6a1 was not significantly changed in livers of Atg5 deficient mice or upon alcohol 
treatment (Supplemental Fig.S10).  
The protein level of ADH, CYP2E1, and ALDH1/2 were further analyzed. Protein stability of 
CYP2E1 is critical to its induction by alcohol 54. The protein level of CYP2E1 and ADH was 
decreased in older (18 to 24 wk) (Fig.7C and D) and younger (8 to 11 wk) (Supplemental 
Fig.S11) Atg5-deficient livers. However, consistent to previous studies 54, the protein level of 
CYP2E1 was significantly increased after alcohol treatment in livers of both Atg5∆hep mice and 
Atg5F/F mice (Fig.7C and D, Supplemental Fig.S9). No consistent changes in ADH or ALDH1/2 
in either older (18 to 24 wk) or younger (8 to 1 wk) mice was observed (Fig.7C and D, 
Supplemental Fig.S9). The gene expression and protein expression data indicated that Atg5 
deficiency in the liver altered expression of genes related to alcohol metabolism; however, 
alcohol itself did not affect the mRNA level of most of these genes.  These changes could result 
in a lower metabolism of alcohol and therefore a lower level of metabolites of alcohol that are 
known to be responsible for its toxicity.  
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The lower metabolism of alcohol might cause a higher plasma alcohol level in the Atg5-deficient 
mice.  To examine this possibility, Atg5∆hep and Atg5F/F mice were given a single dose of alcohol 
by gavage, and the plasma levels of alcohol were measured at different time points (Fig.7E). 
The plasma alcohol in untreated mice was undetectable. The plasma level of alcohol at 1h after 
gavage was comparable between Atg5∆hep and Atg5F/F mice, suggesting that there was no 
difference in the intestinal absorption of alcohol (Fig.7E). Interestingly, plasma levels of alcohol 
were slightly lower at 3h and dramatically lower at 9h in Atg5∆hep mice than those in Atg5F/F mice 
(Fig.7E). These results indicated an increased plasma alcohol clearance in Atg5∆hep mice 
despite a reduction in the expression of genes in the alcohol metabolism pathway. Other 
mechanisms may therefore account for the alcohol elimination in the autophagy deficient mice.  
 
DISCUSSION 
The effect of autophagy on alcohol-induced liver injury is affected by how autophagy is 
inhibited and how alcohol is administered  
This is the first study in which the role of autophagy in alcohol-induced liver injury was assessed 
through a genetic approach to disrupt the formation of autophagosomes using either inducible 
or constitutive knockout of two different autophagy genes, Atg7 and Atg5. These models differ in 
the duration of autophagy deficiency, the specific gene being affected, and the severity of 
endogenous liver injury.  This study thus allows an extensive analysis of the interaction of 
alcohol administration and autophagy function in the context of acute and chronic liver injury.  
Previous studies had examined the role of autophagy by using siRNA-mediated knockdown of 
Atg7, or by interference of the lysosomal functions with chloroquine or TFEB 8, 9, 12, 15, 31. In these 
studies, the protective role of autophagy in alcohol-induced liver injury had been shown in the 
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models of an acute binge, a chronic 4-week Liber-DeCarli feeding, and a chronic-plus-binge 
feeding. The protective effects of autophagy in the gastric infusion model had also been 
observed with the use of chloroquine (Zhou and Yin, unpublished observations). In the infusion 
model alcohol (up to 37.1% of calorie uptake) was given in either a 8% low fat or 40% high fat 
base over a period of 28 days55. Administration of chloroquine led to increased hepatic G and 
blood ALT.  
Here we have confirmed the protective effect of autophagy in the inducible Atg7-deficient livers 
(Atg7∆hep-ERT2) using both the acute binge model and a new chronic-plus-binge model. In both 
models autophagy deficiency via Atg7 deletion was induced only shortly before alcohol 
treatment. The inducible approach minimized the liver injury caused by autophagy deficiency 
alone so that the impact of autophagy deficiency on alcohol-induced injury can be directly 
examined.  However, mice harboring constitutive deletion of Atg7 (Atg7∆hep) had different 
responses to alcohol treatment in the acute binge and chronic-plus-binge models. Liver injury 
was noticeably enhanced in Atg7∆hep mice following the chronic-plus-binge treatment, but not 
following acute binge treatment. The difference in the liver injury following alcohol treatments 
between the two Atg7 deletion models may be due to the difference in the duration of gene 
deletion, which would result in varying levels of autophagy dysfunction and liver injury.  It is 
possible that a higher level of detrimental SQSTM1/p62 accumulation and NRF2 activation 
Atg7∆hep mice (Fig. 3B-C vs Fig. 2B-C) may account for this resistance. 
For mice with constitutive Atg5 deletion in the liver (Atg5∆hep), liver injury was noticeably 
enhanced following a single dose of binge treatment, but paradoxically improved following the 
chronic-plus-binge treatment.  In the latter, the improved presentation included a lower blood 
level of liver enzymes and total bile acids and a reduced hepatic inflammation, ductular reaction, 
and fibrosis.  It is possible that the level of NRF2 activation could be in part responsible for the 
difference between the Atg5∆hep and Atg7∆hep mice.  Thus the levels of SQSTM1/p62 and NQO1 
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were higher in the Atg7∆Hep liver than in the Atg5∆Hep livers (Fig. 3B-C vs Fig. 4B-C). The extent 
of NRF2 activation may determine the severity of endogenous injury 41, 48, 56, which in turn affect 
the response to alcohol treatment.  
These results demonstrate that the outcomes of the interaction of alcohol and hepatic 
autophagy function could depend on how autophagy function is disabled, constitutively or 
acutely, which autophagy gene is deleted, Atg7 or Atg5, and how alcohol is administrated.  
However, published and current results clearly demonstrate that acute inactivation of autophagy 
or lysosome function, via genetic, chemical (siRNA), or pharmacological approach, promotes 
alcohol-induced liver injury in a variety of alcohol administration models with different dosages 
and durations.  But the more complex findings of alcohol-induced phenotypes in chronic 
autophagy deficient mice perhaps more realistically reflect clinical scenarios in which autophagy 
functions could be compromised through a more chronic process by alcohol and other co-
existing factors such as viral infection 16-19 or high fat diet 13, 14, 15. 
The variable liver pathology in Atg5∆hep and Atg7∆hep mice may contribute to their 
differential responses to alcohol given through different regimes  
Embryonic deletion of Atg5 or Atg7 in the parenchymal cells under the albumin promotor leads 
to severe liver pathology 48, 56. Both Atg7 and Atg5 are critical for LC3 to conjugate to 
phosphatidylalcoholamine (PE) on the autophagosomal membrane, which is required for 
autophagosome formation. However, the hepatic phenotypes of Atg5∆hep and Atg7∆hep mice are 
interestingly different in the degree and progression of the injury. Overall Atg5∆hep mice seemed 
to present a less severe phenotype of liver injury (Fig. 1B-1C). Similar observations could be 
found in earlier sudies 48, 56. In addition, Atg5-deficient mice seem to undergo a spontaneous 
improvement when they became older (four months and beyond) (Fig. 4F-H and 56).  Also, the 
improvement was mainly contributed by the male mice (Supplemental Fig S4A), not the female 
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mice (Supplemental Fig. S5A). The mechanisms for the more severe phenotype of Atg7∆hep mice 
are not clear, but may be related to the more critical function of ATG7 being the only E1-like 
molecule responsible for both ATG5-ATG12 conjugation and LC3-PE conjugation 5.  
Alternatively, the possibility that ATG7 might have additional functions cannot be ruled out.   
The mild liver injury associated with Atg5-deficiency could allow the detection of the added 
alcohol-induced insults in the acute binge model (Fig. 1B).  On the other hand, Atg7∆hep mice 
might have a blunted response to an acute alcohol binge, and failed to show an increased 
injury.  Since the elevation of hepatic TG level is an immediate consequence of alcohol 
stimulation and steatosis is a major pathological phenomenon in AFLD.46, 47, the change in the 
hepatic total TG level was examined in Atg7∆hep and Atg5∆hep mice.  Indeed, TG level was not 
elevated in Atg7∆hep (Fig. 1C) but was elevated in Atg5∆hep (Fig. 1B) mice receiving an acute 
binge treatment.  This observation supported that Atg7∆hep mice had a blunted response to acute 
alcohol stimulation.  In the chronic-plus-binge regime, Atg7∆hep mice responded to the prolonged 
alcohol stimulation since the total TG level was elevated (Fig. 3E), and consequently an 
elevated injury was observed (Fig. 3D).  
The response of Atg5∆hep mice to the chronic-plus-binge treatment was unexpected. The liver 
injury phenotypes was paradoxically reduced in these mice despite that they seemed to respond 
to alcohol as evidenced by elevated hepatic TG level (Fig. 4I-J).  The improvement in liver injury 
despite an elevation in hepatic TG was evident in both sexes and regardless the age 
(Supplemental Fig. S4 and Supplemental Fig. S5). An earlier study had also shown that Atg5∆hep 
mice were paradoxically resistant to acetaminophen-induced liver injury as well 57. A common 
feature of alcohol- and acetaminophen-induced liver injury is the induction of oxidative stress. 
Thus it is possible that Atg5∆hep mice had pathological changes that render them to be resistant 
to oxidative stress.  
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Deletion of either Atg5 or Atg7 in the liver causes SQSTM1/p62 accumulation in the liver, which 
in turn activates NRF2 40, 41, 56, 58. The latter may create a somewhat reduced environment to 
resist damages caused by oxidative stress 57.  However, the elevated NRF2 activation in 
autophagy deficiency is in fact correlated with the pathology as co-deletion of NRF2 blocked 
most of the liver phenotypes in Atg7∆hep and Atg5∆hep mice41, 48, 56. Thus the improved hepatic 
presentation of Atg5∆hep mice given chronic-plus-binge alcohol treatment may be due to other 
factors.   
The effect of alcohol in mice with chronic liver injury due to autophagy deficiency is thus 
complicated by the baseline liver changes in autophagy deficient condition. It thus has to be 
cautious in reaching conclusive remarks on the potential mechanisms that are involved.  
Notably, clinically alcoholic liver disease is often complicated by other conditions such as viral 
infection16-19 and NAFLD13, 14, 15, both of which could compromise autophagy functions.  Long-
term alcohol use can also suppress autophagy by itself 9, 10, 11, 12, 15.  This study demonstrated 
that the effects of alcohol can be quite diverse in livers with a varying degree of autophagy 
deficiency.  
Improvement of liver injury in Atg5∆hep mice by chronic alcohol treatment may be related 
to multiple factors  
Other factors to consider include the potential role of inflammation, which is known to play 
important roles in the pathogenesis of ALFD 49,50.  The reduced injury in Atg5∆hep livers by the 
chronic alcohol treatment may be related to reduced Inflammation.  In addition, changes related 
to metabolism of bile acids and alcohol itself may deserve attentions as well.   
As previously piblished52, 56, Atg5∆hep and Atg7∆hep mice develop cholestatic injury, which is 
accompanied with increased level of CK19-positive ductular cells (ductular reaction), altered 
mRNA level of genes in the bile acid metabolism pathways, and an increase of circulating TBA 
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level. Interestingly, several studies showed a relationship between alcohol administration and 
BA metabolism 59-61. Indeed, serum level of TBA was decreased by alcohol treatment in both 
Atg5F/F and Atg5∆hep mice. However, the improving effect in Atg5∆hep mice by alcohol may not be 
related to intrahepatic BA metabolism since the hepatic BA level in Atg5∆hep remained high 
(Fig.6D-6E) and the expression of genes that are related to BA metabolism did not change 
significantly (Supplemental Fig.S9). Nevertheless, this reduction in serum TBA may still be 
beneficial as suggested by the decrease in ductular reaction (Fig.6A) and serum ALT/AST 
(Fig.4F-4G). How chronic alcohol treatment and Atg5-deficiency lead to improved cholestatic 
outcome is an interesting topic for future studies.  
Alcohol is generally metabolized in hepatic parenchymal cells, which express the highest levels 
of alcohol-oxidizing enzymes, including ADHs, CYP2E1, and CAT 46. The first step of alcohol 
breakdown in the liver by these enzymes generates toxic metabolites, including acetaldehyde 
and other potentially damaging molecules 53. Interestingly, the mRNA level of ADHs, Cyp2e1, 
and Cat genes was decreased in Atg5-deficient livers. Reduced levels of these alcohol oxidizing 
enzymes may reduce the generation of toxic metabolites, and thus less or no alcohol-mediated 
toxicity. However, there was no consistent difference in the expression of these genes between 
Atg5∆hep livers and Atg7∆hep livers (data not shown), which may thus not account for the 
difference in how these mice responded to alcohol.  
The toxic acetaldehyde can be enzymatically removed by acetaldehyde dehydrogenase (Aldh).  
Aldh2 is one of the most important Aldh family genes for alcohol metabolism. Either 
pharmacological activation of Aldh2 or global Aldh2 overexpression seem to ameliorate chronic 
alcohol-induced hepatic steatosis and improved ALD 62, 63. Aldh2 deficiency paradoxically 
resulted in improve alcoholic fatty livers although worsen liver inflammation and fibrosis 64. The 
expression of several Aldh genes, including Aldh2, was decreased in Atg5-deficient livers 
although the protein level remained unchanged. The significance of this change is not known, 
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but the overall findings would suggest that alcohol metabolism might be altered in Atg5∆hep 
livers, which may contribute to the observed phenotypes.  
A lower expression of these enzymes may result in a slower blood alcohol clearance, as in 
Adh1 and Adh4 knockout mice 65.  Surprisingly, a faster clearance rate of plasma alcohol in 
Atg5∆hep mice was observed.  It is notable that alcohol could be cleared from circulation by other 
mechanisms independent of these enzymes, such as through breath.  The potential involvement 
of these independent mechanisms needs to be investigated in the future.  
In summary, this study has demonstrated a protective role of autophagy in alcohol-induced liver 
injury, which was best illustrated in models where an autophagy gene, Atg7, is acutely deleted. 
In mice with constitutive deletion of Atg7 or Atg5, the impacts of autophagy deficiency on 
alcohol-induced liver phenotype become complicated, in large part due to the co-existence of 
liver pathology caused by autophagy deficiency. Collectively, this study indicates the complexity 
of the relationship between autophagy status and alcohol-induced liver injury. This relationship 
is dictated by the timing of the autophagy inhibition and alcohol exposure, the regime of alcohol 
administration, and the particular autophagy gene being inactivated. These conditions may draw 
some similarities to the clinical alcoholic liver diseases, which is often complicated by additional 
confounding factors, such as viral infection16-19 and NAFLD13, 14, 15, in which autophagy function 
can be compromised. This study may provide a model to understand the complex interactions of 
alcohol with autophagy deficiency at various degrees caused by other underlying conditions. 
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FIGURE LEGENDS 
Fig. 1 Genetic deletion of autophagy genes exacerbates liver injury induced by acute 
alcohol binge. A: Scheme of acute binge treatment. Mice were treated with a single dose of 
alcohol or the same volume of distilled water by gavage after six hours of fasting. Mice were 
euthanized 16 hours later. B-C: Liver weight and body weight ratio (%), the serum levels of ALT, 
AST, ALP, and the hepatic levels of triglycerides (TG) and total cholesterol (TCHO) were 
measured in liver-specific Atg5 (B, 8 to 34 wk old, n=7 to 14) and Atg7 (C, 8 to 16 wk old, n=3 to 
6) deficient mice. D: Scheme of the administration of alcohol to Atg7∆hep-ERT2 mice. Tamoxifen 
(TMX) was injected at day 1 and day 2 to induce the deletion of Atg7. Alcohol or water was then 
given by oral gavage on day 8. Atg7F/F mice were used as control. E: Liver weight and body 
weight ratio (%), the serum levels of ALT, AST, ALP, and the hepatic levels of TG and TCHO 
were measured in induced Atg7∆hep-ERT2 mice (8 to 15 wk old, n=3 to 5). *P < 0.05 versus non-
treated F/F control; †P < 0.05 versus non-treated ∆Hep control, ‡ P < 0.05 versus treated F/F 
control. 
Fig.2 Acute deletion of Atg7 enhances alcohol-induced liver injury in a chronic-plus-
binge model. A: Scheme of the chronic-plus-binge treatment. Mice were acclimatized with 
liquid diet for 5 days. Atg7F/F and Atg7∆hep-ERT2 mice were injected with TMX at day 3 and day 4 
during acclimatization. After acclimatization, mice were randomly divided into two groups and 
given a liquid diet with alcohol (EtOH-fed) or with maltose dextrin (Pair-fed) for 10 days, followed 
by a single gavage of alcohol (5g/kg) or iso-caloric maltose dextrin. Mice were analyzed nine 
hours later. B: Representative western blot images of protein expression in the livers of Atg7F/F 
and Atg7∆hep-ERT2 mice following alcohol or pair-fed treatment. *non-specific bands. C: 
Densitometry of each protein band was conducted. The density of ATG7, P62, or NQO1 was 
normalized to that of β-Actin. The density of LC3II was normalized to that of LC3I. These values 
were expressed as fold change over those of pair-fed Atg7F/F mice (n=4). D: The mRNA level of 
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Gstm1 and Nqo1 in the livers of Atg7F/F and Atg7∆hep-ERT2 mice following alcohol or pair-fed 
treatment. Expression levels were normalized to that of β-Actin and expressed as the fold 
change over those of pair-fed Atg7F/F (n=4). E-F: Liver weight and body weight ratio (%), serum 
levels of ALT, AST, ALP, and TBA in Atg7F/F and Atg7∆hep-ERT2 mice following alcohol or pair-fed 
treatment. G: Hepatic TG and serum β-hydroxybutyrate (β-OHB) levels in Atg7F/F and Atg7∆hep-
ERT2
 mice given alcohol or pair-fed treatment. Mice were used at the age of 8 to 12 wk, n=4 to 
11. Gstm1: glutathione S-transferase M1, and Nqo1: NAD(P)H quinone dehydrogenase 1 
(Nqo1). *P < 0.05 versus non-treated F/F control; †P < 0.05 versus non-treated ∆Hep control, 
‡P < 0.05 versus treated F/F control. 
Fig.3 Constitutive deletion of hepatic Atg7 enhances alcohol-induced liver injury in a 
chronic-plus-binge model. A: Scheme of the chronic-plus-binge treatment. Atg7F/F and 
Atg7∆hep mice were acclimatized with liquid diet for five days. After acclimatization, mice were 
randomly divided into two groups and given alcohol or control diet as in Fig.2. B: Representative 
western blot images of protein expression in the liver from Atg7F/F and Atg7∆hep mice following 
alcohol or pair-fed treatment. SE: short exposure; LE: long exposure. C: The density of ATG7, 
P62, or NQO1 was normalized to that of GAPDH. The density of LC3II was normalized to that of 
LC3I. These values were expressed as fold change over those of pair-fed Atg7F/F mice (n=3). D-
E: Liver weight and body weight ratio (%), serum levels of ALT, AST, ALP, and TBA in Atg7F/F 
and Atg7∆hep mice following alcohol or pair-fed treatment. F: Hepatic TG and TCHO levels in 
Atg7F/F and Atg7∆hep mice given alcohol or pair-fed treatment. Mice were used at the age of 8 to 
15 wk, n=3 to 5. *P < 0.05 versus non-treated F/F control; †P < 0.05 versus non-treated ∆Hep 
control, ‡P < 0.05 versus treated F/F control. 
Fig.4 Constitutive deletion of hepatic Atg5 does not enhance liver injury in a chronic-
plus-binge model. A: Scheme of the chronic-plus-binge alcohol treatment. Atg7F/F and Atg7∆hep-
ERT2
 mice were injected with TMX at day 3 and day 4 during acclimatization. After 
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acclimatization, mice were randomly divided into two groups and given a liquid diet with alcohol 
(EtOH-fed) or with maltose dextrin (Pair-fed) for 10 days, followed by a single gavage of alcohol 
(5g/kg) or iso-caloric maltose dextrin. Mice were analyzed nine hours later.  B: Representative 
western blot images of protein expression in the liver from Atg5F/F and Atg5∆hep mice following 
alcohol or pair-fed treatment. Anti-ATG12 antibody was used to detect the ATG12-ATG5 
conjugate. C: The density of ATG5-ATG12, P62, or NQO1 was normalized to that of β-Actin. 
The density of LC3II was normalized to that of LC3I. These values were expressed as fold 
change over pair-fed Atg5F/F mice (n=4). D: The mRNA level of Gstm1 and Nqo1 in livers of 
Atg5F/F and Atg5∆hep mice following alcohol or pair-fed treatment. Expression levels were 
normalized to that of β-Actin and expressed as the fold change over those of pair-fed Atg5F/F 
(n=6). E-H: Liver weight and body weight ratio (%), serum levels of ALT, AST, and ALP in 
Atg5F/F and Atg5∆hep mice following alcohol or pair-fed treatment (n=7-18). I-L:. Hepatic TG and 
TCHO levels in Atg5F/F and Atg5∆hep mice given alcohol or pair-fed treatment. *P < 0.05 versus 
non-treated F/F control; †P < 0.05 versus non-treated ∆Hep control, ‡P < 0.05 versus treated 
F/F control. 
Fig.5 Reduced inflammation and fibrosis in constitutive Atg5-deficient livers following 
chronic-plus-binge alcohol treatment. A-E: Atg7F/F and Atg7∆hep-ERT2 mice (18 to 24 weeks 
old) were injected with TMX at day 3 and day 4 during acclimatization. After acclimatization, 
mice were randomly divided into two groups and given a liquid diet with alcohol (EtOH-fed) or 
with maltose dextrin (Pair-fed) for 10 days, followed by a single gavage of alcohol (5g/kg) or iso-
caloric maltose dextrin. Mice were analyzed nine hours later. Liver sections were subjected to 
hematoxylin and eosin (H-E) staining (A), F4/80 stain and quantified (B-C), and Masson's 
trichrome stain and quantified (D-E). F: The hepatic hydroxyproline level was determined (n=5 
to 6). G: Representative western blot images of α-SMA protein and densitometric analysis. The 
density of α-SMA protein was normalized to that of β-Actin and expressed as the fold change 
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over those of Atg5F/F mice given the pair-fed diet (n=4). H: The mRNA expression of fibrosis-
related genes in the livers of Atg5F/F and Atg5∆hep mice given alcohol or control diet. Expression 
levels of indicated genes were determined by RT-qPCR and were normalized to that of β-Actin 
and expressed as the fold change over Atg5F/F mice given pair-fed treatment (n=6). *P < 0.05 
versus non-treated F/F control; †P < 0.05 versus non-treated ∆Hep control, ‡P < 0.05 versus 
treated F/F control. α-SMA: α-smooth muscle actin, Ctgf: connective tissue growth factor, Tgf-β: 
transforming growth factor beta 1, Timp1: TIMP metallopeptidase inhibitor 1, and Gfap: glial 
fibrillary acidic protein. 
Fig.6 Reduced cholestasis in constitutive Atg5-deficient livers following chronic-plus-
binge alcohol treatment. A-B: Atg7F/F and Atg7∆hep-ERT2 mice (18 to 24 weeks old) were 
injected with TMX at day 3 and day 4 during acclimatization. After acclimatization, mice were 
randomly divided into two groups and given a liquid diet with alcohol (EtOH-fed) or with maltose 
dextrin (Pair-fed) for 10 days, followed by a single gavage of alcohol (5g/kg) or iso-caloric 
maltose dextrin. Mice were analyzed nine hours later. Liver sections were immunostained with 
anti-CK19 (A). CK19 positive areas (n=4 to 5) were quantified. C: Serum levels of total bile 
acids (TBA; both sexes, n=11 to 18; Male, n=6 to 12; Female, n=4 to 7). D-E: The levels of TBA 
in each gram of liver (D) or in the whole liver (E) were determined (all sexes, n=6; male only, 
n=3; or female only, n=3).  *P < 0.05 versus non-treated F/F control; †P < 0.05 versus non-
treated ∆Hep control, ‡P < 0.05 versus treated F/F control. Scale bar: 0.1mm 
Fig.7 Constitutive deletion of hepatic Atg5 alters the expression of genes related to 
alcohol metabolism and serum alcohol clearance. A-B: Atg7F/F and Atg7∆hep-ERT2 mice (18 to 
24 weeks old) were injected with TMX at day 3 and day 4 during acclimatization. After 
acclimatization, mice were randomly divided into two groups and given a liquid diet with alcohol 
(EtOH-fed) or with maltose dextrin (Pair-fed) for 10 days, followed by a single gavage of alcohol 
(5g/kg) or iso-caloric maltose dextrin. Mice were analyzed nine hours later. The mRNA levels of 
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genes related to the oxidation of alcohol (A) or acetaldehyde (B) in the liver (n=6). C: The 
protein levels of key alcohol metabolizing enzymes in the liver. β-Actin (for Cyp2E1) and 
GAPDH (for ALDH1/2 and ADH) were used as loading control. D: Densitometry was conducted, 
and the density levels were normalized to that of loading control and expressed as fold change 
over Atg5F/F mice given pair-fed treatment (n=4). E: Atg5F/F and Atg5∆hep mice at the age of 13 to 
20 wk were given a single dose of alcohol binge (5 g/kg, n=3 to 5). Plasma alcohol 
concentration were then measured at 1, 3, and 9 hours later. *P < 0.05 versus non-treated F/F 
control; †P < 0.05 versus non-treated ∆Hep control, ‡P < 0.05 versus treated F/F control (A, B, 
and D); ***P < 0.001 (E). 
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Table 1. Antibody list. 
     
Antibody name Company Catalog # Host 
ACTIN (8H10D10)) Cell Signaling 3700 mouse 
ADH Santa Cruz sc-133207 mouse 
ALDH1/2 Santa Cruz sc-166362 mouse 
ATG12 Cell Signaling 2011 rabbit 
ATG7 Cell Signaling 2631 rabbit 
CK19 DSHB TROMA-III Rat 
CYP2E1 Enzo Life Sciences BML-CR3271 Rabbit 
GAPDH Novus biologicals NB 300-221 mouse 
LC3B Sigma L7543 rabbit 
NQO1 Abcam ab34173 rabbit 
SQSTM1/P62 Abnova H00008878-M01 mouse 
Smooth Muscle Actin (α-SMA) Thermo  PA5-19465 rabbit 
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Table 2. Primer list. 
     
Gene/primer 
name 
  Sequence (Forward)   Sequence (Reverse) 
Acaca 
 
5’-GCCTCTTCCTGACAAACGAG-3’   5’-TGACTGCCGAAACATCTCTG-3’ 
Acadl 
 
5’-GGTGGAAAACGGAATGAAAGG-3’  5’-GGCAATCGGACATCTTCAAAG-3’ 
Acadm 
 
5’-TGTTAATCGGTGAAGGAGCAG-3’  5’-CTATCCAGGGCATACTTCGTG-3’ 
Acox1 
 
5’-CATATGACCCCAAGACCCAAG-3’  5’-CATGTAACCCGTAGCACTCC-3’ 
Actin 
 
5’-ACTATTGGCAACGAGCGGTT-3’  5’-CAGGATTCCATACCCAAGAAGGA-3’ 
Adh1 
 
5’-TGTTGAGAGCGTTGGAGAAG-3’  5’-CGCTTCGGCTACAAAAGTTG-3’ 
Adh4 
 
5’-GTAGACTCTGTCCCAAACCTG-3’  5’-AAGGTCAGGATTGTTCGGATG-3’ 
Adh5 
 
5’-AAATCTCCACTCGTCCATTCC-3’  5’-CACTCTCCACACTCTTCCATC-3’ 
Adh7 
 
5’-GGTTGTGGAGAGTGTTGGAG-3’  5’-CCTGTCAGATCGCTCCTAATG-3’ 
Akr1d1 
 
5’-CTCATTGGGCTTGGAACCTA-3’  5’-CATTGATGGGACATGCTCTG-3’  
Aldh16a1 
 
5’-GAGGTTCGAGATGGAGATGTG-3’  5’-AAAGAGAAAGGAGTCGGCAG-3’ 
Aldh18a1 
 
5’-CAGACATCGTGGAGGGAAAG-3’  5’-CTGTTCAGGCTCTAAGGTAGC-3’ 
Aldh1a1 
 
5’-ATCACTGTGTCATCTGCTCTG-3’  5’-CCCAGTTCTCTTCCATTTCCAG-3’ 
Aldh1a2 
 
5’-ATGGATGCGTCTGAAAGAGG-3’  5’-TGACTCCCTGCAAATCGATG-3’ 
Aldh1a3 
 
5’-AACAAGATAGCCTTCACCGG-3’  5’-CCAAGTCCAAGTCAGCATCT-3’ 
Aldh1b1 
 
5’-GGAGTCTTATGTCTTGGATCTGG-3’  5’-TGTCGGGTGAAGCAGAAATG-3’ 
Aldh1l1 
 
5’-CATCCAGACCTTCCGATACTTC-3’  5’-ACAATACCACAGACCCCAAC-3’ 
Aldh1l2 
 
5’-CATTGACAGCCCAAAGCATG-3’  5’-CCCAGAAAACAGAAAACCCAG-3’ 
Aldh2 
 
5’-TGCAGGAGAATGTGTATGACG-3’  5’-CGATTTGATGTAGCCGAGGATC-3’ 
Aldh3a1 
 
5’-GGCGTGGTCCTTGTCATAG-3’  5’-AGGGATAAGTGTTGAAAGCAGG-3’ 
Aldh3a2 
 
5’-AGCCCTTGTTACATTGACAGAG-3’  5’-TTCATGTACTTTCCCCAGGC-3’ 
Aldh3b1 
 
5’-C TTCGGTCTGGTGCTTATC-3’  5’-ACCTCAGCCAGTATCTTTTCAG-3’ 
Aldh3b2 
 
5’-GAATCAGATGTTGGAACGCAC-3’  5’-GGAGAAGGTGTCAAAGGAGAAC-3’ 
Aldh4a1 
 
5’-CGATAAGTCTACTGGGTCTGTG-3’  5’-GGGCTTATGAGTCTCCTTGATG-3’ 
Aldh5a1 
 
5’-CCAAGATCATAACAGCCGAGAG-3’  5’-TCGCTTATCTTTGGCAGAGG-3’ 
Aldh6a1 
 
5’-AAGGGAAGACTCTTGCTGATG-3’  5’-GAGGCAGACGGTAGGAATAAAG-3’ 
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Aldh7a1 
 
5’-AGATATTCCTGCCCCAAAACG-3’  5’-CTGAACCTCGCCTATTCCTTC-3’ 
Aldh8a1 
 
5’-GTATGCATTACACCGTTCGC-3’  5’-AAGTCATCTCACTGGGCTTG-3’ 
Aldh9a1 
 
5’-CTGGAATACTATGCAGGGCTG-3’  5’-GCGATCTGGAAGGGATAGTTC-3’ 
Apob 
 
5’-ATTCGAGCACAGATGACCAG-3’  5’-GTACCTTTCACCATCAGACTCC-3’ 
Apoe 
 
5’-CAATTGCGAAGATGAAGGCTC-3’  5’-TAATCCCAGAAGCGGTTCAG-3’ 
Bsep 
 
5’-CTGCCAAGGATGCTAATGCA-3’   5’-CGATGGCTACCCTTTGCTTCT-3’  
Cat 
 
5’-CTCGTTCAGGATGTGGTTTTC-3’  5’-CTTTCCCTTGGAGTATCTGGTG-3’  
Ccl2 
 
5’-GTCCCTGTCATGCTTCTGG-3’  5’-GCTCTCCAGCCTACTCATTG-3’ 
Ccl3 
 
5’-TTCTCTGTACCATGACACTCTGC-3’   5’-CGTGGAATCTTCCGGCTGTAG-3’  
Ccr2 
 
5’-GCTCTACATTCACTCCTTCCAC-3’  5’-ACCACTGTCTTTGAGGCTTG-3’ 
Cd36 
 
5’-GCGACATGATTAATGGCACAG-3’  5’-GATCCGAACACAGCGTAGATAG-3’ 
Collagen-1I 
 
5’-ACGGCTGCACGAGTCACAC-3’  5’-GGCAGGCGGGAGGTCTT-3’  
Ctgf 
 
5’-GGGCCTCTTCTGCGATTTC-3’   5’-ATCCAGGCAAGTGCATTGGTA-3’ 
Cyp27a1 
 
5’-GCCTCACCTATGGGATCTTCA-3’   5’-TCAAAGCCTGACGCAGATG-3’  
Cyp2e1 
 
5’-TCACTGGACATCAACTGCC-3’  5’-TGGTCTCTGTTCCTGCAAAG-3’ 
Cyp3A11 
 
5’-CAGAAGCACCGAGTGGATTT-3’   5’-GACTGGGCTGTGATCTCCAT-3’  
Cyp7a1 
 
5’-AACAACCTGCCAGTACTAGATAGC-3’  5’-GTGTAGAGTGAAGTCCTCCTTAGC-3’  
Cyp7b1 
 
5’-CAGCTATGTTCTGGGCAATG-3’   5’-TCGGATGATGCTGGAGTATG-3’  
Cyp8b1 
 
5’-AGTACACATGGACCCCGACATC-3’  5’-GGGTGCCATCCGGGTTGAG-3’ 
F4/80 
 
5’-TGCATCTAGCAATGGACAGC-3’   5’-GCCTTCTGGATCCATTTGAA-3’ 
Fabp1 
 
5’-TCTCCGGCAAGTACCAATTG-3’  5’-TTGATGTCCTTCCCTTTCTGG-3’ 
Fasn 
 
5’-CCCTTGATGAAGAGGGATCA-3’  5’-ACTCCACAGGTGGGAACAAG-3’  
Fgfr4 
 
5’-CTGCCAGAGGAAGACCTCAC-3’   5’-GTAGTGGCCACGGATGACTT-3’  
Fxr (Nr1h4) 
 
5’-GGCCTCTGGGTACCACTACA-3’  5’-TGTACACGGCGTTCTTGGTA-3’ 
Gfap 
 
5’-GAAAACCGCATCACCATTCC-3’  5’-CTTAATGACCTCACCATCCCG-3’ 
Gstm1 
 
5’-ACTTGATTGATGGGGCTCAC-3’   5’-TCTCCAAAATGTCCACACGA-3’ 
Hsd3b7 
 
5’-CCATCCACAAAGTCAACGTG-3’  5’-CTCCATTGACCTTCCTTCCA-3’  
Ifng 
 
5’-GATGCATTCATGAGTATTGCCAAGT-3’  5’-GTGGACCACTCGGATGAGCTC-3’  
Il6 
 
5’-AGTTGCCTTCTTGGGACTGA-3’  5’-TCCACGATTTCCCAGAGAAC-3’  
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Lcn2 
 
5’-CTACAATGTCACCTCCATCCTG-3’  5’-ACCTGTGCATATTTCCCAGAG-3’ 
Lipe (Hsl) 
 
5’-CTGAGATTGAGGTGCTGTCG-3’  5’-CAAGGGAGGTGAGATGGTAAC-3’ 
Lpl 
 
5’-AACAAGGTCAGAGCCAAGAG-3’  5’-CCATCCTCAGTCCCAGAAAAG-3’ 
Ly6g 
 
5’-CACCTGAGACTTCCTGCAAC-3’  5’-CTTCTATCTCCAGAGCAACGC-3’ 
Mrp2 (Abcc2) 
 
5’-GCACTGTAGGCTCTGGGAAG-3’   5’-TGCTGAGGGACGTAGGCTAT-3’ 
Mrp3 
 
5’-GGACTTCCAGTGCTCAGAGG-3’  5’-AGCTGTGGCCTCGTCTAAAA-3’ 
Mrp4 
 
5’-TGTTTGATGCACACCAGGAT-3’  5’-GACAAACATGGCACAGATGG-3’  
Nqo1 
 
5’-GCACTGATCGTACTGGCTCA-3’  5’-CATGGCATAGAGGTCCGACT-3’  
Ost-α 
 
5’-GTCTCAAGTGATGAACTGCCA-3’  5’-TTGAGTGCTGAGTCCAGGTC-3’  
Ost-β 
 
5’-GTATTTTCGTGCAGAAGATGCG-3’   5’-TTTCTGTTTGCCAGGATGCTC-3’ 
Pnpla2 (Atgl) 
 
5’-ATATCCCACTTTAGCTCCAAGG-3’  5’-CAAGTTGTCTGAAATGCCGC-3’ 
Pparg 
 
5’-ATGCCAGTACTGCCGTTTTC-3’   5’-GGCCTTGACCTTGTTCATGT-3’ 
Saa2 
 
5’-CAGGATGAAGCTACTCACCAG-3’  5’-CTTCATGTCAGTGTAGGCTCG-3’ 
Scd1 
 
5’-TTCTTACACGACCACCACCA-3’   5’-CCGAAGAGGCAGGTGTAGAG-3’  
Slc10a1 
(Ntcp)  
5’-CACCATGGAGTTCAGCAAGA-3’  5’-CCAGAAGGAAAGCACTGAGG-3’  
Slco1a1 
(Oatp1) 
 
5’-ATCCAGTGTGTGGGGACAAT-3’  5’-GCAGCTGCAATTTTGAAACA-3’  
Tgfb 
 
5’-CACCGGAGAGCCCTGGATA-3’   5’-TGTACAGCTGCCGCACACA-3’  
Timp1 
 
5’-ATTCAAGGCTGTGGGAAATG-3’   5’-CTCAGAGTACGCCAGGGAAC-3’  
Tlr4 
 
5’-TTCAGAACTTCAGTGGCTGG-3’  5’-TGTTAGTCCAGAGAAACTTCCTG-3’ 
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